GSK Fails To Save Diabetes Drug Injection Patent
GSK has lost its bid to reinstate a patent for a method of injecting drugs to lower blood sugar levels, after European officials found that the British pharmaceutical giant had not...To view the full article, register now.
Already a subscriber? Click here to view full article